DRUG · COUNSELLING NOTES
Donanemab
Kisunla
Updated
New prescription
indication: _____. IV q4 weeks in clinic; MRI monitoring; warned on allergies; serious/common AEs: ARIA (brain swelling/bleed), infusion reaction; non-pharm: routines, caregiver support.
Refill prescription
refilled, adherence discussed, no SEs were reported
Dose change
Dose change discussed. new dose reviewed; IV q4 weeks in clinic; MRI monitoring; warned on allergies; serious/common AEs: ARIA (brain swelling/bleed), infusion reaction; non-pharm: routines, caregiver support.